We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+13.92%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$419M
AUM Growth
+$51.7M
Cap. Flow
+$5.75M
Cap. Flow %
1.37%
Top 10 Hldgs %
31.11%
Holding
110
New
12
Increased
24
Reduced
47
Closed
9

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.11M
2
CPRI icon
Capri Holdings
CPRI
+$5.87M
3
MCK icon
McKesson
MCK
+$3.46M
4
COR icon
Cencora
COR
+$3.16M
5
GGG icon
Graco
GGG
+$3.13M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$6.63M
2
EBAY icon
eBay
EBAY
+$5.21M
3
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
+$4.96M
4
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$3.38M
5
TS icon
Tenaris
TS
+$3.29M

Sector Composition

Rank Sector Weight
1 Healthcare 28.9%
2 Financials 15.15%
3 Industrials 14.25%
4 Consumer Discretionary 10.89%
5 Technology 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILMN icon
1
Illumina
ILMN
$27.9B
$19.1M 4.56%
177,690
+5,397
+3% +$494K
AAPL icon
2
Apple
AAPL
$4.79T
$17.6M 4.2%
878,108
+50,260
+6% +$950K
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.35T
$14.5M 3.46%
518,858
-38,985
-7% -$986K
BIIB icon
4
Biogen
BIIB
$30.1B
$12.7M 3.04%
45,570
+2,720
+6% +$704K
MA icon
5
Mastercard
MA
$483B
$12.6M 3%
150,460
+41,810
+38% +$3.11M
MCK icon
6
McKesson
MCK
$97.6B
$11.7M 2.79%
72,325
+22,500
+45% +$3.46M
GILD icon
7
Gilead Sciences
GILD
$166B
$11.4M 2.73%
152,318
+1,700
+1% +$118K
HSIC icon
8
Henry Schein
HSIC
$9.87B
$10.9M 2.6%
243,398
-2,282
-0.9% -$99.8K
DFS
9
DELISTED
Discover Financial Services
DFS
$10M 2.39%
179,100
+23,900
+15% +$1.25M
ALXN
10
DELISTED
Alexion Pharmaceuticals
ALXN
$9.79M 2.34%
73,650
-55,250
-43% -$6.63M
SRCL
11
DELISTED
Stericycle Inc
SRCL
$9.53M 2.27%
82,051
-7,875
-9% -$918K
ESRX
12
DELISTED
Express Scripts Holding Company
ESRX
$9.27M 2.21%
132,003
-24,900
-16% -$1.63M
MMM icon
13
3M
MMM
$84.1B
$9.2M 2.2%
78,458
+16,744
+27% +$1.78M
MGA icon
14
Magna International
MGA
$18.2B
$9.03M 2.15%
220,000
+39,600
+22% +$1.64M
DHR icon
15
Danaher
DHR
$143B
$8.56M 2.04%
165,001
+38,238
+30% +$1.88M
PRGO icon
16
Perrigo
PRGO
$1.47B
$8.18M 1.95%
53,300
-1,700
-3% -$245K
QCOM icon
17
Qualcomm
QCOM
$183B
$7.75M 1.85%
104,400
-4,800
-4% -$339K
CELG
18
DELISTED
Celgene Corp
CELG
$7.59M 1.81%
+89,800
New +$7.11M
V icon
19
Visa
V
$689B
$7.4M 1.77%
133,000
-13,200
-9% -$666K
SBUX icon
20
Starbucks
SBUX
$119B
$7.34M 1.75%
187,400
-3,000
-2% -$119K
WFC icon
21
Wells Fargo
WFC
$264B
$7.26M 1.73%
159,900
– –
CLB icon
22
Core Laboratories
CLB
$520M
$7.05M 1.68%
36,900
-350
-0.9% -$65.1K
NKE icon
23
Nike
NKE
$64.1B
$6.81M 1.63%
173,200
+10,800
+7% +$413K
STX icon
24
Seagate
STX
$184B
$6.76M 1.61%
120,300
+8,600
+8% +$425K
PG icon
25
Procter & Gamble
PG
$348B
$6.75M 1.61%
82,963
-205
-0.2% -$16.7K
1
2 3 4 5

Similar funds

ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
PLU
Performa Ltd (US) Charleston, South Carolina $442M AUM 13.84% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $440M AUM 17.66% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return

De Burlo Group's Q4 2013 Portfolio in Review

As of Q4 2013, De Burlo Group held 110 positions worth $419M, up 14% from $367M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

De Burlo Group's Q4 2013 filing shows 12 new, 24 increased, 47 reduced and 9 closed positions. Its largest new stake was Celgene Corp: 89,800 shares worth $7.59M. The largest sale was Alexion Pharmaceuticals, an estimated $6.63M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.

  • De Burlo Group's largest Q4 2013 buy was Celgene Corp: 89,800 shares worth $7.59M.
  • De Burlo Group added most to McKesson in Q4 2013, an estimated $3.46M increase.
  • De Burlo Group's biggest Q4 2013 reduction was Alexion Pharmaceuticals, cutting an estimated $6.63M.
  • De Burlo Group fully exited eBay in Q4 2013, selling an estimated $5.21M.
  • De Burlo Group's ten largest holdings make up 31% of its $419M portfolio in Q4 2013.
  • De Burlo Group opened 12 new positions and closed 9 in Q4 2013.
  • De Burlo Group's portfolio value rose 14% quarter-over-quarter to $419M.

Based on De Burlo Group's 13F filing for Q4 2013, filed 7 Feb 2014.